MDxHealth

MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic products to personalize the diagnosis and treatment of prostate cancer and other urological conditions. The company’s tests are based on proprietary genetic, epigenetic, and other complex molecular technologies. MDxHealth is committed to delivering highly accurate and clinically actionable urology solutions that inform patient diagnosis and treatment while improving healthcare economics for payers and providers.